mercredi 27 mai 2015

Onco Actu du 27 mai 2015

2.7 Etiologie - Obésité

Obesity in teen boys may increase bowel cancer risk in later life [NHS Choices]

3. Prévention

Mediterranean-style diet may halve womb cancer risk, study suggests [The Guardian]

4.5 Dép., diag. & prono. - Colorectal

Doctors’ lapse may explain some minority lag in colon cancer screens [Reuters]

5. Traitements

World first as viral immunotherapy for skin cancer shows patient benefit in Phase III trial [The Institute of Cancer Research]

MRNAs produced only in ovarian cancer cells discovered [UT SanDiego]

Skin cancer patients successfully treated with herpes-based drug [The Guardian]

Genetically engineered virus 'cures' patients of skin cancer [The Telegraph]

5.2 Pharma

Sanofi’s Global Head for Prostate Drug, Zhen Su, Leaves Company [Bloomberg]

5.2.1 Pharma - Partenariats

Bluebird Adds to CAR-T Arsenal With Five Prime Antibody Deal [Xconomy]

bluebird bio and Five Prime Therapeutics Enter into License Agreement for Novel Antibodies to Develop Chimeric Antigen Receptor T Cell Therapy [Five Prime]

5.3.4 Traitements - AMM (FDA, EMA)

Janssen Receives Positive CHMP Opinion Recommending IMBRUVICA® (ibrutinib) for the Treatment of Waldenström’s Macroglobulinemia [Johnson & Johnson]

5.4 Traitements - Economie

Sanofi prostate cancer drug to remain on CDF [Pharmafile]

Big Bets on Proton Therapy Face Uncertain Future [Wall Street Journal]

New Push Ties Cost of Drugs to How Well They Work [Wall Street Journal]

5.5 ASCO

Visit the CancerLinQ™ Booth at ASCO’s Annual Meeting to View the System’s First-Ever Demonstration [ASCO]

5.5.1 ASCO (général)

June 1 Press Briefing at ASCO Annual Meeting to Announce Innovations in Precision Medicine for the 21st Century [ASCO]

5.5.10 ASCO (hémato)

51st Annual Meeting of the American Society of Clinical Oncology (ASCO) [Erytech]

5.5.11 ASCO (SNC]

NewLink Genetics to Present Poster on Indoximod, an IDO Pathway Inhibitor, at American Society of Clinical Oncology (ASCO) Annual Meeting [NewLing Genetics]

6. Lutte contre les cancers

Complexities of Cancer Explained for Patient Benefit [CANCER RESEARCH Catalyst]

6.1 Observation

Family history may not impact breast cancer survival odds [Reuters]

6.11 Patients

Welcome to the revolution! The changing role of patient advocates within research [Cancer World]

6.5 Médecines alternatives

Younger cancer patients more open to alternative therapies [Reuters]

6.7 DMP, Big Data & applis

Tech Rivalries Impede Digital Medical Record Sharing [NY Times]

Books: Review: ‘The Digital Doctor’ by Robert Wachter Weighs Medicine’s Technological Transformation [NY Times]